Silke Brüderlein

4.4k citations
65 papers · 3.5k indexed · 1 hit paper · h-index 30

Impact in

Papers in

Silke Brüderlein

64 papers receiving 3.5k citations

Hit Papers

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. 1993 · 567 citations
5671993202620042015100200300400500

Peers

Silke Brüderlein
Comparison fields: 5 of 110
  • Pathology and Forensic Medicine 711
  • Oral Surgery 258
  • Cancer Research 532
  • Immunology 746
  • Rheumatology 505
Replace Teiichi Motoyama with:
Teiichi Motoyama Japan
Rotraud Wieser Austria
Richard S. Camplejohn United Kingdom
Jean Benhattar Switzerland
Maria Zieleńska Canada
Ester Piek Netherlands
Torahiko Nakashima Japan
Chantal Desmaze France
G R Mundy United States
Moying Yin United States
Silke Brüderlein relative to Teiichi Motoyama Japan Teiichi Motoyama's profile →
Citations per field
00.5×3.0×
Teiichi Motoyama · 1×
Citations per year

Countries citing papers authored by Silke Brüderlein

Since Specialization
Citations

This map shows the geographic impact of Silke Brüderlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Brüderlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Brüderlein more than expected).

Fields of papers citing papers by Silke Brüderlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Brüderlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Brüderlein. The network helps show where Silke Brüderlein may publish in the future.

Co-authors

The 25 scholars most cited alongside Silke Brüderlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silke Brüderlein Line = papers co-authored together Silke Brüderlein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201724
2 201565
3 201427
4 201437
5 201018
6 20076
7 200553
8 20056
9 200416
10 20034
11 200211
12 200167
13 199840
14 19972
15 199714
16 199234
17 199266
18 199027
19 1989146
20 19892

About Silke Brüderlein

Silke Brüderlein is a scholar working on Aging, Pathology and Forensic Medicine, Immunology and Allergy, Genetics and Cancer Research, having authored 65 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Telomeres, Telomerase, and Senescence (7 papers), DNA Repair Mechanisms (7 papers), Sarcoma Diagnosis and Treatment (7 papers), Bone Tumor Diagnosis and Treatments (7 papers), Cell Adhesion Molecules Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (711 citations), Oral Surgery (258 citations), Cancer Research (532 citations), Immunology (746 citations) and Rheumatology (505 citations). Silke Brüderlein has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Peter Möller, Frank Leithäuser, Peter Mӧller, C. Henne, K Koretz, Peter H. Krammer, Cornelia Hasel, Jens Dhein, Ingo Melzner and Gunhild Mechtersheimer. Their work appears in journals such as Blood, International Journal of Cancer, Genes Chromosomes and Cancer, The Journal of Pathology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026